Srividya Ramachandran, Ph.D. - Publications
Affiliations: | 2010 | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Immunology, Virology BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2017 | Treat BR, Bidula SM, Ramachandran S, St Leger AJ, Hendricks RL, Kinchington PR. Influence of an immunodominant herpes simplex virus type 1 CD8+ T cell epitope on the target hierarchy and function of subdominant CD8+ T cells. Plos Pathogens. 13: e1006732. PMID 29206240 DOI: 10.1371/Journal.Ppat.1006732 | 0.554 | |||
2013 | Ramachandran S, Knickelbein JE, Ferko C, Hendricks RL, Kinchington PR. Corrigendum to "Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters" [Virology 378 (2008) 254-264] Virology. 435: 504. DOI: 10.1016/J.Virol.2012.10.014 | 0.538 | |||
2010 | Ramachandran S, Davoli KA, Yee MB, Hendricks RL, Kinchington PR. Delaying the expression of herpes simplex virus type 1 glycoprotein B (gB) to a true late gene alters neurovirulence and inhibits the gB-CD8+ T-cell response in the trigeminal ganglion. Journal of Virology. 84: 8811-20. PMID 20573821 DOI: 10.1128/Jvi.00496-10 | 0.587 | |||
2008 | Ramachandran S, Knickelbein JE, Ferko C, Hendricks RL, Kinchington PR. Development and pathogenic evaluation of recombinant herpes simplex virus type 1 expressing two fluorescent reporter genes from different lytic promoters. Virology. 378: 254-64. PMID 18619637 DOI: 10.1016/J.Virol.2008.05.034 | 0.585 | |||
2007 | Ramachandran S, Kinchington PR. Potential prophylactic and therapeutic vaccines for HSV infections. Current Pharmaceutical Design. 13: 1965-73. PMID 17627530 DOI: 10.2174/138161207781039760 | 0.502 | |||
Show low-probability matches. |